Figure 4
Outcomes in the pivotal Left Atrial Appendage System Embolic Protection in Patients with Atrial Fibrillation (PROTECT AF) trial.53 CV, cardiovascular; ITT, intention-to-treat (Reproduced from Piccini JP, Sievert H, Patel MR: Left atrial appaendage occlusion: rationale, evidence, devices and patient selection. Eur. Heart J, 2017;38: 869–876., with permission).

Outcomes in the pivotal Left Atrial Appendage System Embolic Protection in Patients with Atrial Fibrillation (PROTECT AF) trial.53 CV, cardiovascular; ITT, intention-to-treat (Reproduced from Piccini JP, Sievert H, Patel MR: Left atrial appaendage occlusion: rationale, evidence, devices and patient selection. Eur. Heart J, 2017;38: 869–876., with permission).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close